ProFibrix profibrix.com


Public lists: Pharma Startups (6570)

ProFibrix leverages its expertise in fibrinogen technology to develop and market products for the hemostasis and regenerative medicine markets. Human fibrinogen plays a pivotal role in blood clotting and tissue healing. ProFibrix is led by a team with commercial, clinical and scientific experience in the field of hemostasis. Fibrocaps, the company's lead product, which is based on a mixture of fibrinogen and thrombin, is a dry powder topical tissue sealant that stops acute and severe bleeding du...Show all

ProFibrix leverages its expertise in fibrinogen technology to develop and market products for the hemostasis and regenerative medicine markets. Human fibrinogen plays a pivotal role in blood clotting and tissue healing. ProFibrix is led by a team wit...Show all

Company (Acquired)

Phone: +31 88 86 69 665

Fax:

Zernikedreef 9

Leiden, 2333 CK
Netherlands

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
ProFibrix $40.4M Aug 6, 2013
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related ProFibrix Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors

Board Members

Competitors

Company Status Description Investors

Knopp Biosciences

Pittsburgh, Pennsylvania, United States
Alive / ActiveKnopp Biosciences is a drug discovery and development company focused on delivering treatments for unmet medical needs through experience and partnership. The company's clinical and preclinical programs focus on mechanisms of mitochondrial energetics and its lead compound, dexpramipexole, is currently in Phase 3 clinical development for amyotrophic lateral sclerosis. Additional programs include dexpramipexole combination therapy for Parkinson's disease and the discovery of ion channel modulators...Show allLogin to see details

Indel Therapeutics

Vancouver, British Columbia, Canada
Alive / ActiveIndel Therapeutics Inc. is a Vancouver-based biotechnology company dedicated to discovering and developing drugs for difficult to treat infections, with a focus on the growing critical unmet needs of hospital-acquired and antibiotic resistant infections. Invented by Dr. Neil Reiner and his colleagues at the University of British Columbia, the company's drug discovery platform technology is based on a paradigm-breaking approach to find new antibacterial, antifungal and anti-parasitic drugs by goi...Show allLogin to see details
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Fibrinogen preparations enriched in fibrinogen with an extended alpha chain Oct 07, 2015 Jul 04, 2017 Patent
Powder delivery device Dec 15, 2009 Dec 08, 2015 Patent
Dry powder fibrin sealant May 28, 2010 Sep 01, 2015 Patent
Treatment of tissue adhesion May 28, 2010 Jul 28, 2015 Patent
Dry powder fibrin sealant Jan 07, 2011 Sep 30, 2014 Patent
See all 8 patents